Clinical trial
The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous…
NCT00407771 · Jordan Hospital, Other · Unknown status
Key facts
| NCT number | NCT00407771 |
|---|---|
| Title | The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention |
| Official title | A Pilot Study of The Effects of a Single High Dose Bolus Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention |
| Lead sponsor | Jordan Hospital, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Tirofiban |
| Enrollment | 44 |
| Start date | Nov 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Dec 5, 2006 |
| Last update posted | Oct 31, 2007 |
| Countries | Jordan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: